The relationship between early embryo development and tumourigenesis

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 12, 2010, Pages 2697-2701

  Ma, Yanlei ^a   Zhang, Peng ^a   Wang, Feng ^a   Yang, Jianjun ^a   Yang, Zhe ^a   Qin, Huanlong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Cancer; Developmental biology; Embryo; Tumourigenesis

Indexed keywords

TUMOR MARKER;

ANIMAL; ANIMAL EMBRYO; ARTICLE; CANCER INVASION; CELL TRANSFORMATION; EMBRYO DEVELOPMENT; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; EPIGENESIS, GENETIC; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650074133     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01191.x     Document Type: Article

References (52)

1. Snider P, Conway SJ. Developmental biology: the power of blood. Nature. 2007; 450: 180-1.
2. Papaioannou VE. Ontogeny, pathology, oncology. Int J Dev Biol. 1993; 37: 33-7.
3. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001; 414: 105-11.
4. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100: 57-70.
5. Pierce GB. The cancer cell and its control by the embryo. Rous-Whipple Award lecture. Am J Pathol. 1983; 113: 117-24.
6. Williams JW 3rd, Carlson DL, Gadson RG, et al . Cytogenetic analysis of triploid renal carcinoma in Rana pipiens. Cytogenet Cell Genet. 1993; 64: 18-22.
7. Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene. 2001; 20: 8085-91.
8. Bignold LP, Coghlan BL, Jersmann HP. Hansemann, Boveri, chromosomes and the gametogenesis-related theories of tumours. Cell Biol Int. 2006; 30: 640-4.
9. Wang Y. Wnt/Planar cell polarity signaling: a new paradigm for cancer therapy. Mol Cancer Ther. 2009; 8: 2103-9.
10. Ma Y, Peng J, Liu W, et al. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol Cell Proteomics. 2009; 8: 1878-90.
11. Wilczynski JR. Cancer and pregnancy share similar mechanisms of immunological escape. Chemotherapy. 2006; 52: 107-10.
12. Xie K, Abbruzzese JL. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell. 2003; 4: 245-7.
13. Wu F, Stutzman A, Mo YY. Notch signaling and its role in breast cancer. Front Biosci. 2007; 12: 4370-83.
14. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004; 10: 789-99.
15. Murray MJ, Lessey BA. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Semin Reprod Endocrinol. 1999; 17: 275-90.
16. Monk M, Boubelik M, Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development. 1987; 99: 371-82.
17. Monk M. Variation in epigenetic inheritance. Trends Genet. 1990; 6: 110-4.
18. Gama-Sosa MA, Slagel VA, Trewyn RW, et al. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 1983; 11: 6883-94.
19. Goelz SE, Vogelstein B, Hamilton SR, et al. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science. 1985; 228: 187-90.
20. Feinberg AP, Gehrke CW, Kuo KC, et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 1988; 48: 1159-61.
21. Monk M, Adams RL, Rinaldi A. Decrease in DNA methylase activity during preimplantation development in the mouse. Development. 1991; 112: 189-92.
22. Kautiainen TL, Jones PA. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture. J Biol Chem. 1986; 261: 1594-8.
23. El-Deiry WS, Nelkin BD, Celano P, et al. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer. Proc Natl Acad Sci U S A. 1991; 88: 3470-4.
24. Baudino TA, McKay C, Pendeville-Samain H, et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 2002; 16: 2530-43.
25. Wenzel PL, Wu L, De Bruin A, et al. Rb is critical in a mammalian tissue stem cell population. Genes Dev. 2007; 21: 85-97.
26. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965; 122: 467-81.
27. Nap M, Mollgard K, Burtin P, et al. Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult. Tumour Biol. 1988; 9: 145-53.
28. Chen H, Egan JO, Chiu JF. Regulation and activities of alpha-fetoprotein. Crit Rev Eukaryot Gene Expr. 1997; 7: 11-41.
29. Gitlin D, Perricelli A, Gitlin GM. Synthesis of alpha-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res. 1972; 32: 979-82.
30. Cataltepe S, Gornstein ER, Schick C, et al. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem. 2000; 48: 113-22.
31. Dibbelt L, Knuppen R, Bobrowski A. Squamous cell carcinoma antigen immunoactivity is normal in maternal serum but high and increasing in amniotic fluid during pregnancy. Clin Chem. 1992; 38: 2161-2.
32. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997; 3: 917-21.
33. Megliorino R, Shi FD, Peng XX, et al. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detect Prev. 2005; 29: 241-8.
34. Hohlfeld P, Dang TT, Nahoul K, et al. Tumour-associated antigens in maternal and fetal blood. Prenat Diagn. 1994; 14: 907-12.
35. Engelen MJ, De Bruijn HW, Hollema H, et al. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors. Gynecol Oncol. 2000; 78: 16-20.
36. Chu TM. Prostate-specific antigen and early detection of prostate cancer. Tumour Biol. 1997; 18: 123-34.
37. Yu H, Berkel H. Prostate-specific antigen (PSA) in women. J La State Med Soc. 1999; 151: 209-13.
38. Kassanos D, Botsis D, Rizos D, et al. Tissue polypeptide specific antigen (TPS) throughout normal pregnancy. Anticancer Res. 2000; 20: 2129-31.
39. Sarandakou A, Malamitsi-Puchner A, Protonotariou E, et al. Indicative markers of cell proliferation and apoptosis during the perinatal period. Am J Perinatol. 2003; 20: 283-8.
40. Vaitukaitis JL. Human chorionic gonadotropin-a hormone secreted for many reasons. N Engl J Med. 1979; 301: 324-6.
41. Avgidou K, Papageorghiou A, Bindra R, et al. Prospective first-trimester screening for trisomy 21 in 30, 564 pregnancies. Am J Obstet Gynecol. 2005; 192: 1761-7.
42. Inglot AD, Gelder F, Georgiades JA. Tumor-associated antigens are cytokine inducers and hyporeactivity factors to the immune system. Biotherapy. 1998; 11: 27-37.
43. Cheli CD, Morris DL, Neaman IE, et al. Measurement of four tumor marker antigens in the sera of pregnant women. J Clin Lab Anal. 1999; 13: 35-9.
44. Dvorak P, Dvorakova D, Hampl A. Fibroblast growth factor signaling in embryonic and cancer stem cells. FEBS Lett. 2006; 580: 2869-74.
45. Wang Y, Steinbeisser H. Molecular basis of morphogenesis during vertebrate gastrulation. Cell Mol Life Sci. 2009; 66: 2263-73.
46. Katoh M. Networking of WNT, FGF, Notch, BMP, and Hedgehog signaling pathways during carcinogenesis. Stem Cell Rev. 2007; 3: 30-8.
47. Papaioannou VE, Waters BK, Rossant J. Interactions between diploid embryonal carcinoma cells and early embryonic cells. Cell Differ. 1984; 15: 175-9.
48. Tzukerman M, Rosenberg T, Reiter I, et al. The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res. 2006; 66: 3792-801.
49. Durr M, Harder F, Merkel A, et al. Chimaerism and erythroid marker expression after microinjection of human acute myeloid leukaemia cells into murine blastocysts. Oncogene. 2003; 22: 9185-91.
50. Hochedlinger K, Blelloch R, Brennan C, et al. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 2004; 18: 1875-85.
51. Cheng TC, Huang CC, Chen CI, et al. Leukemia inhibitory factor antisense oligonucleotide inhibits the development of murine embryos at preimplantation stages. Biol Reprod. 2004; 70: 1270-6.
52. Zhang Y, Yeh JR, Mara A, et al. A chemical and genetic approach to the mode of action of fumagillin. Chem Biol 2006; 13: 1001-9.